Voyager Therapeutics, Inc. logo

Voyager Therapeutics, Inc.

NASDAQ:VYGR

Overview | Financials
Company Name Voyager Therapeutics, Inc.
Symbol VYGR
Currency USD
Price 6.23
Market Cap 339,742,459
Dividend Yield 0%
52-week-range 5.97 - 11.72
Industry Biotechnology
Sector Healthcare
CEO Dr. Alfred W. Sandrock Jr., M.D., Ph.D.
Website https://www.voyagertherapeutics.com

An error occurred while fetching data.

About Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral

Related Stocks

Verastem, Inc. logo

Verastem, Inc.

VSTM

2.71 USD

Liquidia Corporation logo

Liquidia Corporation

LQDA

9.91 USD

The Joint Corp. logo

The Joint Corp.

JYNT

11.47 USD

Theratechnologies Inc. logo

Theratechnologies Inc.

THTX

1.2 USD

Ocular Therapeutix, Inc. logo

Ocular Therapeutix, Inc.

OCUL

9.05 USD

Financials

Numbers are in millions USD

Numbers are in millions USD